What is it about?
The aim of this study was to assess acylated and non-acylated poly(glycerol adipate) polymers (PGA) as suitable nanoparticulate systems for encapsulation and release of ibuprofen, ibuprofen sodium salt (IBU-Na) and ketoprofen as model drugs. Drug encapsulated nanoparticles were prepared using the interfacial deposition method in the absence of surfactants. Physicochemical characterisation studies of the produced loaded nanoparticles showed that drug-polymer interactions depend on the characteristics of the actual active substance. IBU-Na showed strong interactions with the polymers and it was found to be molecularly dispersed within the polymer matrix while ibuprofen and ketoprofen retained their crystalline state. The drug release profiles showed stepwise patterns which involve an initial burst release effect, diffusion of the drug from the polymer matrix and eventually drug release possibly via a combined mechanism. PGA polymers can be effectively used as drug delivery carriers for various active substances.
Featured Image
Why is it important?
PGA polymers can be effectively used as drug delivery carriers for various active substances.
Perspectives
Read the Original
This page is a summary of: Development of poly(glycerol adipate) nanoparticles loaded with non-steroidal anti-inflammatory drugs, Journal of Microencapsulation, July 2012, Taylor & Francis,
DOI: 10.3109/02652048.2012.665087.
You can read the full text:
Contributors
The following have contributed to this page